System from Quest Diagnostics’ products business is first FDA-cleared Herpes Simplex Virus 1 and 2 test that uses genital swab or cerebrospinal fluid (CSF) specimen collection Quest Diagnostics (NYSE: ...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the availability in Europe of the Simplexa C. difficile ...
Quest Diagnostics Incorporated announced that the Simplexa™ Dengue molecular test kit developed by its Focus Diagnostics products business has been registered for distribution in Brazil. The test kit, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback